Biotechnology

Aptevo Therap

Aptevo Therapeutics Showcases APVO451 Preclinical Data

Aptevo Therap released FY2025 Q3 earnings on November 6 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -40.1338 (forecast USD -37.6199)

Aptevo Therap released FY2025 9 Months earnings on November 6 (EST), actual revenue USD 0, actual EPS USD -98.5079

Aptevo Therap released FY2025 Q2 earnings on August 11 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -151.2875 (forecast USD -1.498 K)

Aptevo Therap released FY2025 Semi-Annual earnings on August 11 (EST), actual revenue USD 0, actual EPS USD -30.8373

Aptevo Therapeutics Files Dirk Huebner as Beneficial Owner

Aptevo Therapeutics Switches to New Independent Auditor

Aptevo Therapeutics Inc. Plans to Issue Common Stock

Aptevo Therapeutics Inc. Completes $8 Million Financing

Aptevo Therapeutics Introduces New Candidate Drug APVO455 for Solid Tumors

Aptevo Therapeutics Inc. Issues $8 Million in Stock

Aptevo Therapeutics' AML Bispecific Antibody Trial Yields Positive Results

Aptevo Therapeutics Signs Equity Purchase Agreement with Yorkville

Aptevo Therapeutics Inc. Attends BIO International Convention

Aptevo Therapeutics Announces 1 for 20 Reverse Stock Split

Aptevo Therap released FY2025 Q1 earnings on May 15 (EST), actual revenue USD 0 (forecast USD 0), actual EPS USD -87.8735 (forecast USD -84.2)

Aptevo Reports Q1 Earnings and Mipletamig Clinical Progress

Aptevo Therapeutics Updates Progress on APVO711 Antibody

Aptevo Therapeutics Inc forecasts Q4 EPS loss of 4.21 USD

Aptevo Therapeutics forecasts a loss of $4.21 per share

EKSO Bionics

Profusa

Antelope Enterprise

Cemtrex

Aimei Health Tech

FLY-E

CID Holdco

ON24

Borealis Foods

Zhongchao

Reverse Stock Split

合股

Ex Date: Today 2025.12.30 (EST), 1-for-18 Reverse Stock Split

Please note that a "Suspected value trap" is a stock that appears The stock looks financially sound and severely undervalued, but behind the low valuation is a long-term decline in business capacity or a serious financial crisis, or even the risk of bankruptcy in the short term.

Suspected value trap